Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Which Is the Better Buy: Vertex or Invitae?

TheMotleyFool

0 0

Which Is the Better Buy: Vertex or Invitae?: https://g.foolcdn.com/editorial/images/712860/scientists-examine-cell-make-up-microscope-biotech-1.jpg

Vertex Pharmaceuticals (NASDAQ: VRTX) and Invitae (NYSE: NVTA) have gone in different directions this year when it comes to share price, with Vertex's stock up more than 43% so far and Invitae's shares plunging over 84%.

Looking at these two biotech stocks from a long-term perspective, is Invitae now the better buy? Or is Vertex's strong run this year likely to extend into 2023?

Vertex Pharmaceuticals has had a record year in revenue, thanks to its cystic fibrosis (CF) treatments. The biotech company specializes in small molecule therapies to treat CF, plus a host of other diseases.

Source Fool.com

Like: 0

VRTX

Share